CEO Post: Pfizer Vet Leads 1 New Phase 3 Biotech Firm
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
A former Pfizer executive takes the coveted ceo post at a newly formed biotech company, ready to enter Phase 3 trials. Learn more about this strategic leadership move.
Kering’s new leadership makes incoming ceo pledges to revitalize the luxury group. Discover the key strategies planned to get the company’s ‘mojo back’.
A long-time Pfizer vet has been appointed CEO of a newly formed biotech company. The firm is already poised to enter phase 3 trials for its lead candidate.